Is Abciximab a Superior Way to Eliminate Elevated Thrombotic Risk in Diabetics - ISAR-SWEET

Description:

The goal of the study was to evaluate treatment with the glycoprotein IIb/IIIa inhibitor abciximab compared with placebo in diabetic patients undergoing elective percutaneous coronary intervention (PCI) and pretreated with clopidogrel.